Dabigatran is a Direct Thrombin Inhibitor. The mechanism of action of dabigatran is as a Thrombin Inhibitor. It is grouped under the following drug class(es): Antithrombotic agents. Its therapeutic use is listed as cardiovascular. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Pradaxa, Etexilate mesylate and dabigatran. Its PubChem CID is 216210.
Dabigatran
| CAS No | 211914-51-1 |
|---|---|
| Molecular Formula | C25H25N7O3 |
| Molecular Weight | 471.5 g/mol |
| Synonyms | 3-[[2-[(4-carbamimidoylanilino)methyl]-1-methylbenzimidazole-5-carbonyl]-pyridin-2-ylamino]propanoic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Dabigatran is a Direct Thrombin Inhibitor. The mechanism of action of dabigatran is as a Thrombin Inhibitor. It is grouped under the following drug class(es): Antithrombotic agents.
The listed CAS number is 211914-51-1.
The listed molecular formula is C25H25N7O3.
The listed molecular weight is 471.5 g/mol.
3-[[2-[(4-carbamimidoylanilino)methyl]-1-methylbenzimidazole-5-carbonyl]-pyridin-2-ylamino]propanoic acid.
The source lists Pradaxa, Etexilate mesylate and dabigatran.